An Act to repeal 632.865 (2) and 632.865 (5) (e); to renumber 632.865 (4); to amend 40.51 (8), 40.51 (8m), 66.0137 (4), 120.13 (2) (g), 185.983 (1) (intro.), 609.83, 632.861 (4) (a), 632.865 (1) (ae) and 632.865 (6) (c) 3.; to create 632.861 (1m), 632.861 (3g), 632.861 (3r), 632.861 (4) (e), 632.862, 632.865 (1) (ab) and (ac), 632.865 (1) (an), (aq) and (at), 632.865 (1) (bm), 632.865 (1) (cg) and (cr), 632.865 (2d), 632.865 (2h), 632.865 (2p), 632.865 (2t), 632.865 (4) (b), 632.865 (4m), 632.865 (5d), 632.865 (5h), 632.865 (5p), 632.865 (5t), 632.865 (6) (bm), 632.865 (6) (c) 3m., 632.865 (6g), 632.865 (6r) and 632.865 (8) of the statutes; Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 4/9/2025 Asm. | Introduced by Representatives Novak, Tranel, Allen, Armstrong, Brooks, Callahan, Fitzgerald, B. Jacobson, Joers, Kirsch, Kitchens, Knodl, Kreibich, McCarville, Miresse, Mursau, O'Connor, Sortwell, Tittl, Wichgers and Tucker; cosponsored by Senators Felzkowski, Marklein, Cabral-Guevara, Dassler-Alfheim, Drake, Habush Sinykin, L. Johnson, Keyeski, Larson, Nass, Pfaff, Quinn, Ratcliff, Roys, Spreitzer, Wanggaard, Wimberger and James | |
| 4/9/2025 Asm. | Read first time and referred to Committee on Health, Aging and Long-Term Care | |
| 4/11/2025 Asm. | Representative Rivera-Wagner added as a coauthor | |
| 4/23/2025 Asm. | Fiscal estimate received | |
| 5/22/2025 Asm. | Representative Ortiz-Velez added as a coauthor | |
| 5/29/2025 Asm. | Senator Smith added as a cosponsor |
